NeuroNews issue 51 – OUS

6244

Highlights:

  • New data that “refute” the seminal ARUBA trial’s conclusions on interventional treatments for arteriovenous malformations (AVMs) as well as several other highlights from this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA)
  • Laurent Pierot (Reims, France) discusses what the future landscape of endovascular aneurysm care may look like, speculating on the evolving roles for coiling, flow diversion and intrasaccular devices
  • Among a plethora of late-breaking presentations from the 2023 European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) are fresh evidence favouring thrombectomy in large-core stroke patients, “fantastic news” relating to intravenous tenecteplase, and positive results from the INTERACT3 and ENRICH trials assessing intracranial haemorrhage (ICH) treatments
  • PROFILE: Ameer Hassan (Harlingen, USA) outlines how an early-career switch from plastic surgery to vascular neurology has ultimately seen him ascend to president of the Society of Vascular and Interventional Neurology (SVIN)
  • NEUROMODULATION: Pain physicians urge the Cochrane Library to retract and revise a recent review of spinal cord stimulation (SCS) for low back pain, citing “striking errors” across the publication

LEAVE A REPLY

Please enter your comment!
Please enter your name here